In addition to ICAM-1, other studies have reported adipocyte-derived EVs (CD14+) to interfere with insulin signaling in both the liver [49] and skeletal muscle [50] via transfer of adipokine content, thereby inducing insulin resistance [46]. The gene discussed is INS; the disease is Insulin resistance.